Delivered strategic project management and seamless technology transfer, empowering TxCell’s commercial manufacturing scalability and operational success.
Case Studies
Supporting Commercial Scale-up and Technology Transfer

The Challenge: Scaling for Commercial Viability
TxCell (now owned by Sangamo Therapeutics) needed comprehensive support to scale their processes, manage complex project coordination, and facilitate technology transfer for commercial manufacturing and supply.
Our Approach
We provided integrated project management, coordinated process adaptation for scaled-up production and quality control, conducted capacity analysis, and managed technology transfer activities to selected commercial manufacturing organisations (CMOs).
Deliverables
The Outcome
Impact

Our strategic support enabled TxCell to achieve seamless process adaptation, efficient scale-up, and successful technology transfer, significantly enhancing their commercial readiness and operational capabilities.
Case Studies
See how eXmoor Pharma has helped biotech innovators scale their therapies with precision and efficiency.

Streamlining AAV Manufacturing for Clinical Scale-Up
Achieved GMP compliance through advanced optimisation, significantly enhancing yield and accelerating clinical readiness for a European biotech client’s AAV gene therapy.
Optimising iPSC Manufacturing for Clinical Success
Transformed academic iPSC processes into GMP-ready clinical manufacturing strategies, overcoming significant scalability and regulatory hurdles for innovative cell therapy development.
Let’s Accelerate Your Therapy Together
Whether you’re in early-stage development or scaling up for commercial production, eXmoor Pharma provides the expertise and flexibility you need. Partner with us to move your therapy forward with confidence.